1996Xinxiang yixueyuan xuebaoRequires access

Determination about primary drug resistance in mycobacterium tuberculosis from first visit pulmonary tuberculosis type III

Le Guo, Feng Quo

Open publisher page 0 citations

Abstract

Objective To provide scientific basis for selectchemical--drug in treatment of Pulmonary tuberculosis.Method Using Resenbach's culturemedium, drug 92 strains form first visitpulmonary tuberculosis type ill were performed in8 kinds of drugS which were used to treatpulmonary,tuberculosis.Rewlts The drug-- resistant rates of 92mycobacterium tuberculosis strains of first visitpulmonary tuberculosis was 72.8% alxl were inturn SM 50. 0%. INH44. 6%. RFP25. 0%.EMB21. 7%. KMg. 8%, PASS. 7%,CPM4.3%, 1321TH2.2% .The drug--resistant toboth i aam 2 -kinds of drubs was 52. 2%.drug--rmistant to both H aam R was 120 sthem21 .7%.Coecluaioes The drug-- resistufit rates toS. H. R and E are higher and the measurement ofdrug-- resistant is necessary for first visit treatedI vpulmo nary tuberculosis.The drug--nsistant sthemto 1 and 2 kinds drubs is co ̄nly4' andconbined chemotherapy for first visit PUlmonary issuitable.

About this research paper

What this paper is about

Objective To provide scientific basis for selectchemical--drug in treatment of Pulmonary tuberculosis.Method Using Resenbach's culturemedium, drug 92 strains form first visitpulmonary tuberculosis type ill were performed in8 kinds of drugS which were used to treatpulmonary,tuberculosis.Rewlts The drug-- resistant rates of 92mycobacterium tuberculosis strains of first visitpulmonary tuberculosis was 72.8% alxl were inturn SM 50. 0%. INH44. 6%. RFP25. 0%.EMB21. 7%. KMg. 8%, PASS. 7%,CPM4.3%, 1321TH2.2% .The drug--resistant toboth i aam 2 -kinds of drubs was 52. 2%.drug--rmistant to both H aam R was 120 sthem21 .7%.Coecluaioes The drug-- resistufit rates toS. H. R and E are higher and the measurement ofdrug-- resistant is necessary for first visit treatedI vpulmo nary tuberculosis.The drug--nsistant sthemto 1 and 2 kinds drubs is co ̄nly4' andconbined chemotherapy for first visit PUlmonary issuitable.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To provide scientific basis for selectchemical--drug in treatment of Pulmonary tuberculosis.Method Using Resenbach's culturemedium, drug 92 strains form first visitpulmonary tuberculosis type ill were performed in8 kinds of drugS which were used to treatpulmonary,tuberculosis.Rewlts The drug-- resistant rates of 92mycobacterium tuberculosis strains of first visitpulmonary tuberculosis was 72.8% alxl were inturn SM 50. 0%. INH44. 6%. RFP25. 0%.EMB21. 7%. KMg. 8%, PASS. 7%,CPM4.3%, 1321TH2.2% .The drug--resistant toboth i aam 2 -kinds of drubs was 52. 2%.drug--rmistant to both H aam R was 120 sthem21 .7%.Coecluaioes The drug-- resistufit rates toS. H. R and E are higher and the measurement ofdrug-- resistant is necessary for first visit treatedI vpulmo nary tuberculosis.The drug--nsistant sthemto 1 and 2 kinds drubs is co ̄nly4' andconbined chemotherapy for first visit PUlmonary issuitable.

Key concepts: Tuberculosis, Mycobacterium tuberculosis, Pulmonary tuberculosis, Medicine, Drug resistance, Drug, Virology, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Determination about primary drug resistance in mycobacterium tuberculosis from first visit pulmonary tuberculosis type III — Research Paper | ScholarLens